Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.02 on Revenues of $9.6M

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.02. Revenue for the quarter came in at $9.6 million, versus $0 reported last year.

Today announced first quarter 2017 financial results with Net Revenues of $9.6 million and Adjusted Earnings of $0.3 million or $0.02 per share. As of March 31, 2017, the Company had approximately $92 million in Total Assets including $50 million in cash and marketable securities.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM